Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Dow
US Army
Mallinckrodt
Queensland Health
Chubb
AstraZeneca
Citi
Argus Health

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020394

« Back to Dashboard

NDA 020394 describes ATROVENT, which is a drug marketed by Boehringer Ingelheim and is included in five NDAs. It is available from two suppliers. There are three patents protecting this drug. Additional details are available on the ATROVENT profile page.

The generic ingredient in ATROVENT is ipratropium bromide. There are eight drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ipratropium bromide profile page.
Summary for 020394
Tradename:ATROVENT
Applicant:Boehringer Ingelheim
Ingredient:ipratropium bromide
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020394
Mechanism of ActionCholinergic Antagonists
Medical Subject Heading (MeSH) Categories for 020394
Suppliers and Packaging for NDA: 020394
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATROVENT ipratropium bromide SPRAY, METERED;NASAL 020394 NDA Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0086 N 0597-0086-76

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SPRAY, METERED;NASALStrength0.042MG/SPRAY
Approval Date:Oct 20, 1995TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Chinese Patent Office
Deloitte
Cipla
Fuji
Fish and Richardson
Healthtrust
US Department of Justice
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.